ScreenerHero

CMND Clearmind Medicine Inc.

NAS · US · Healthcare · Biotechnology · clearmindmedicine.com
6.600USD+13.01%Mkt Cap: 3.35M $P/E: —

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap3.35M USD
Enterprise Value-11.67M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.86M USD
Revenue/Share—
Last Price6.600 USD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA1.32
EV/Revenue—
P/S—
P/B0.97
EPS (TTM)-57.65
EPS (Forward)—
52W Range
5.2500% of range3840.00
52W High3840.00 USD
52W Low5.250 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-323.41%
ROA-63.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-142.87%
Net Debt-14.13M USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity1.49
Current Ratio4.31
Quick Ratio4.28
Book Value/Sh6.04 USD
Cash/Share37.85 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateOct 5, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.507.40K
Float420.71K
Insiders0.03%
Institutions1.21%
Short Interest
Short Ratio0.0d
Short % Float1.06%
Short % Out.1.06%
Shares Short4.47K
Short (prev mo.)6.16K
Technical
SMA 5010.92 (-39.5%)
SMA 20065.26 (-89.9%)
Beta0.46
S&P 52W Chg16.45%
Avg Vol (30d)97.72K
Avg Vol (10d)22.79K
Technical Indicators
RSI (14)35.7
MACD-1.5881
MACD Signal-1.8256
MACD Hist.+0.2375
BB Upper8.362 USD
BB Middle6.728 USD
BB Lower5.094 USD
BB Width48.57%
ATR (14)0.8201 USD
Vol Ratio (20d)1.07x